Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 The National Association of Insurance Commissioners NAIC Valuation of Life Insurance Policies Model Regulation XXX sets forth the valuation requirements for life insurance with nonlevel premiums or nonlevel benefits, including term insurance and universal life with certain underlying guarantees. Panelists discussed the issues around implementation of the requirements. The issues discussed include: • Determination of X factors when no credible company mortality exists • Proper treatment of secondary guarantees in universal life insurance • Preparation of the mortality assumption opinion requirements • Impacts on product development and design

Description: Regulators share their perspective on a variety of issues including statutory reserve related issues. From a session at the 2002 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, September 19–20, 2002

Description: From an interactive forum session at the 2001 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, November 29-30, 2001 Discussion of the major financial reporting issues and concerns of senior actuaries in life insurance companies. Discussion focused cash flow testing methods and interpretation of results.

Description: This meeting session from the April 1982 Society of Actuaries meeting in Orlando, presented a discussion on allocation of assets and investment income. The discussions included: implications of allocating specific assets to particular lines of business, introduction and management of specific allocation procedures, and the principal allocation methods.

Description: 1993 SOA Spring Meeting, Boston. This session addressed the new risk-based capital requirement. Topics included: 1. How reasonable is the framework of basing the formulas on simplistic application of the C-1, C-2, C-3, and C-4 risks? 2. Will this be effective in stanching the proliferation of RBC formulas by the regulatory bodies? 3. Which lines of business are treated relatively badly by the formulas? 4. Is there realistically anything that can be done to prevent company comparisons and renkings? 5. What are the administrative problems faced by the regulators in the oversight process requirement that this will create?

Description: 1993 SOA Annual Meeting, New York. This session provided an update on the appointed actuary. Topics included: 1. Provided preliminary results of a 1992 cash-flow-testing survey that was sent to a number of life companies in the U.S. 2. A discussion of the position taken by one actuary who did not do cash-flow testing in forming an opinion for his company's 1992 annual statement. 3. How to deal with failed scenarios. 4. The evolution of the appointed actuary's role at MetLife. 5. How the process currently works at MetLife. 6. Insights on where MetLife sees the process going.

Description: 1993 SOA Annual Meeting, New York. This session discussion is about the impact of RBC on product design. Topics included: 1. An overview of the regulatory aspects of RBC. 2. How to incorporate RBC into the pricing of insurance products. 3. The small company perspective 4. The application of marginal RBC analysis. 5. A preliminary analysis on RBC covariance between product lines.

Description: From a session at a meeting of the Society of Actuaries held in San Diego, CA, June 22-23, 2000 Panel discussion of the work being done by the Society of Actuaries and the NAIC to further development of a Unified Valuation System.

Description: From the 1985 Valuation Actuary Symposium. A discussion of the principles that should be part of a life insurance valuation. Also discussion of emerging actuarial professional standards of practice and regulatory requirements with respect to methodology for assessing reserve adequacy.

Description: 1988 Valuation Actuary Symposium. This session discussed the current thinking of the Special Advisory Committee on the Valuation Law which was formed by the NAIC to significantly expand the scope and usefulness of the proposed actuarial opinion.